MENU
PILL
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

PILL stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index... Show more

Category: #Trading
PILL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PILL with price predictions
Sep 23, 2026

PILL's Stochastic Oscillator is sitting in oversold zone for 15 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PILL's RSI Indicator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

Following a +9.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where PILL advanced for three days, in 296 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

PILL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PILL as a result. In 79 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for PILL turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 45 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

PILL moved below its 50-day moving average on September 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PILL crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PILL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PILL entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF is 51.02B. The market cap for tickers in the group ranges from 290.69M to 1.03T. LLY holds the highest valuation in this group at 1.03T. The lowest valued company is FULC at 290.69M.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF was 12%. For the same ETF, the average monthly price growth was 19%, and the average quarterly price growth was 215%. OMER experienced the highest price growth at 20%, while RAPP experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) ETF was 12%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 59
Price Growth Rating: 49
SMR Rating: 73
Profit Risk Rating: 69
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
PILL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/